NCT06095960

Brief Summary

The aim of this study is to conduct a comparative effectiveness evaluation using a randomized control trail design among diverse women to compare two postpartum care models: 1) Telehealth Multicomponent Optimal Model (Telehealth MOM) and 2) enhanced standard of care (ESoC). This study will address critical gaps in knowledge about how best to deliver comprehensive postpartum care that ensures timely identification and treatment of complications and meets the needs and preferences of diverse patients, including disproportionately-impacted racial groups and rural residents.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for not_applicable

Timeline
20mo left

Started Feb 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

6 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Feb 2024Dec 2027

First Submitted

Initial submission to the registry

October 17, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 23, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

February 12, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2027

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

February 5, 2026

Status Verified

February 1, 2026

Enrollment Period

3 years

First QC Date

October 17, 2023

Last Update Submit

February 3, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Completion of post-partum 6-week comprehensive visit

    Binary measure (yes/no) of visit completion

    Baseline to 6 weeks post-partum

Study Arms (2)

Telehealth MOM

EXPERIMENTAL

Telehealth MOM. Each patient will receive ESoC which includes: education on the symptoms to watch for and when to call their healthcare provider, an in-person comprehensive postpartum visit around 6 weeks postpartum, and any additional care deemed necessary by their health care providers. Patients in the Telehealth MOM arm will be also provided with a remote monitoring blood pressure cuff and thermometer and will be instructed to take their blood pressure and temperature twice a day for 14 days after discharge from the hospital. A Registered Nurse will monitor blood pressure and temperature readings over the 14-day period and will contact the patient if the readings are out of range to discuss symptoms and the recommend a course of action. A Registered Nurse will conduct an early postpartum telehealth visit between 10-14 days postpartum.

Behavioral: Telehealth MOM

Enhanced Standard of Care

ACTIVE COMPARATOR

Enhanced standard of care (ESoC). Each patient will be provided education on the symptoms to watch for and when to call their healthcare provider. Patients will be scheduled for a comprehensive postpartum visit around 6 weeks postpartum and any additional care deemed necessary by their health care providers.

Other: Enhanced Standard of Care

Interventions

Patients will receive enhanced standard of care which includes: education on symptoms and when to call their healthcare provider, comprehensive 6-week post-partum visit, and any healthcare deemed necessary by providers.

Enhanced Standard of Care
Telehealth MOMBEHAVIORAL

Patients will receive enhanced standard of care plus remote blood pressure monitoring, remote thermometer, and a 10- to 14-day post-partum telehealth visit.

Telehealth MOM

Eligibility Criteria

Age18 Years - 44 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women between 16-35 weeks gestation
  • Age 18-44 years
  • Ability to speak English, Spanish, or Marshallese
  • Participants may have either a vaginal birth or cesarean section birth

You may not qualify if:

  • Type 1 diabetes on an insulin pump followed closely by endocrinology
  • Uncontrolled Type 2 diabetes
  • End stage renal disease followed closely by nephrology
  • ICU admission at any point during pregnancy or delivery hospitalization
  • Other maternal conditions requiring additional surgeries (i.e. cesarean hysterectomy or intrapartum or postpartum oophorectomy/appendectomy)
  • Incarceration
  • Mental disability limiting decision-making capacity
  • Uncontrolled chronic hypertension
  • HELLP syndrome during pregnancy
  • Sickle cell disease
  • Maternal heart condition or heart disease
  • Opioid use disorder
  • Lupus
  • Thrombophilia or blood clots
  • Need for blood transfusion during delivery hospitalization
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

UAMS El Dorado FMC

El Dorado, Arkansas, 71730, United States

NOT YET RECRUITING

UAMS Fayetteville FMC

Fayetteville, Arkansas, 72703, United States

RECRUITING

UAMS Fort Smith FMC

Fort Smith, Arkansas, 72901, United States

RECRUITING

UAMS Jonesboro FMC

Jonesboro, Arkansas, 72401, United States

NOT YET RECRUITING

UAMS Health Women's Center

Little Rock, Arkansas, 72205, United States

RECRUITING

UAMS Springdale FMC

Springdale, Arkansas, 72764, United States

RECRUITING

Study Officials

  • Jennifer Callaghan-Koru, PhD

    University of Arkansas

    PRINCIPAL INVESTIGATOR
  • Pearl McElfish, PhD

    University of Arkansas

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Brett Rowland, MA

CONTACT

Kacie Simpson, BS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 17, 2023

First Posted

October 23, 2023

Study Start

February 12, 2024

Primary Completion (Estimated)

January 30, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

February 5, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations